<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2530-5115</journal-id>
<journal-title><![CDATA[Hospital a Domicilio]]></journal-title>
<abbrev-journal-title><![CDATA[Hosp. domic.]]></abbrev-journal-title>
<issn>2530-5115</issn>
<publisher>
<publisher-name><![CDATA[Centro Internacional Virtual de Investigación en Nutrición (CIVIN)]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2530-51152024000100003</article-id>
<article-id pub-id-type="doi">10.22585/hospdomic.v8i1.210</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Medicamentos peligrosos: resumen normativo]]></article-title>
<article-title xml:lang="en"><![CDATA[Hazardous drugs: regulatory summary]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bernabeu-Martínez]]></surname>
<given-names><![CDATA[Mari Ángeles]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Universitario de San Juan de Alicante Servicio de Farmacia ]]></institution>
<addr-line><![CDATA[Alicante ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2024</year>
</pub-date>
<volume>8</volume>
<numero>1</numero>
<fpage>29</fpage>
<lpage>36</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S2530-51152024000100003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S2530-51152024000100003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S2530-51152024000100003&amp;lng=en&amp;nrm=iso"></self-uri></article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goodman]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Wintrobe]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders]]></article-title>
<source><![CDATA[J Am Med Assoc]]></source>
<year>1946</year>
<volume>132</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>126-32</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Falck]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Gröhn]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sorsa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vainio]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Heinonen]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Holsti]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutagenicity in urine of nurses handling cytostatic drugs]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1979</year>
<volume>1</volume>
<numero>8128</numero>
<issue>8128</issue>
<page-range>1250-1</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Norppa]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Sorsa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vainio]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Gröhn]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Heinonen]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Holsti]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Increased sister chromatid exchange frequencies in lymphocytes of nurses handling cytostatic drugs]]></article-title>
<source><![CDATA[Scand J Work Environ Health]]></source>
<year>1980</year>
<volume>6</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>299-301</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Puckett]]></surname>
<given-names><![CDATA[WH]]></given-names>
</name>
<name>
<surname><![CDATA[Dana]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Nguyen]]></surname>
<given-names><![CDATA[TV]]></given-names>
</name>
<name>
<surname><![CDATA[Theiss]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Matney]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk of handling injectable antineoplastic agents]]></article-title>
<source><![CDATA[Am J Hosp Pharm]]></source>
<year>1982</year>
<volume>39</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1881-7</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Waksvik]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Klepp]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Brøgger]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chromosome analyses of nurses handling cytostatic agents]]></article-title>
<source><![CDATA[Cancer Treat Rep]]></source>
<year>1981</year>
<volume>65</volume>
<numero>7-8</numero>
<issue>7-8</issue>
<page-range>607-10</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nikula]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Kiviniitty]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Leisti]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Taskinen]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Chromosome aberrations in lymphocytes of nurses handling cytostatic agents]]></article-title>
<source><![CDATA[Scand J Work Environ Health]]></source>
<year>1984</year>
<volume>10</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>71-4</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<collab>Hosp Pharm</collab>
<article-title xml:lang=""><![CDATA[Guidelines for safe handling of cytotoxic drugs in pharmacy departments and hospital wards]]></article-title>
<source><![CDATA[Hosp Pharm]]></source>
<year>1981</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>17-20</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<collab>American Society of Hospital Pharmacists</collab>
<article-title xml:lang=""><![CDATA[ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs]]></article-title>
<source><![CDATA[Am J Hosp Pharm]]></source>
<year>1990</year>
<volume>47</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1033-49</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yodaiken]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bennett]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[OSHA work-practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs]]></article-title>
<source><![CDATA[Am J Hosp Pharm]]></source>
<year>1986</year>
<volume>43</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1193-204</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Burroughs]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Connor]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[McDiarmid]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[NIOSH Alert: preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings]]></source>
<year>2004</year>
<publisher-loc><![CDATA[Atlanta, USA ]]></publisher-loc>
<publisher-name><![CDATA[National Institute of Occupational Safety and Health(NIOSH), Department of Health and Human Services, Center for Disease Control and Prevention]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<collab>National Institute of Occupational Safety and Health</collab>
<source><![CDATA[NIOSH list of antineoplastic and other hazardous drugs in healthcare settings 2010]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Atlanta, USA ]]></publisher-loc>
<publisher-name><![CDATA[National Institute of Occupational Safety and Health(NIOSH), Department of Health and Human Services, Center for Disease Control and Prevention]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Connor]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[MacKenzie]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[DeBord]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Trout]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[O'Callaghan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2012]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Atlanta, USA ]]></publisher-loc>
<publisher-name><![CDATA[National Institute of Occupational Safety and Health(NIOSH), Department of Health and Human Services, Center for Disease Control and Prevention]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Connor]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[MacKenzie]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[DeBord]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Trout]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[O'Callaghan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[NIOSH list of antineoplastic and other hazardous drugs in healthcare settings 2014]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Atlanta, USA ]]></publisher-loc>
<publisher-name><![CDATA[National Institute of Occupational Safety and Health(NIOSH), Department of Health and Human Services, Center for Disease Control and Prevention]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Connor]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[MacKenzie]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[DeBord]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Trout]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[O'Callaghan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Atlanta, USA ]]></publisher-loc>
<publisher-name><![CDATA[National Institute of Occupational Safety and Health(NIOSH), Department of Health and Human Services, Center for Disease Control and Prevention]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Connor]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[MacKenzie]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[DeBord]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Trout]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[O'Callaghan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ovesen]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<source><![CDATA[NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2020]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Atlanta, USA ]]></publisher-loc>
<publisher-name><![CDATA[National Institute of Occupational Safety and Health(NIOSH), Department of Health and Human Services, Center for Disease Control and Prevention]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jong de]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Pawlowska-Cyprysiak]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Hildt-Ciupinska]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Bos]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Nicolescu]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Trifu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Current and emerging occupational safety and health (OSH) issues in the healthcare sector, including home and community care: European Risk Observatory Report]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Luxembourg ]]></publisher-loc>
<publisher-name><![CDATA[European Union Publications Office]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herrero Alonso]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Gaspar Carreño]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cercós Lleti]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicamentos peligrosos: una carrera de fondo]]></article-title>
<source><![CDATA[Rev OFIL]]></source>
<year>2018</year>
<volume>28</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>9-10</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Krstev]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Perunicic]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Vidakovic]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Work practice and some adverse health effects in nurses handling antineoplastic drugs]]></article-title>
<source><![CDATA[Med Lav]]></source>
<year>2003</year>
<volume>94</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>432-9</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Crudi]]></surname>
<given-names><![CDATA[CB]]></given-names>
</name>
<name>
<surname><![CDATA[Stephens]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
<name>
<surname><![CDATA[Maier]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Possible occupational hazards associated with the preparation/administration of antineoplastic agents]]></article-title>
<source><![CDATA[NITA]]></source>
<year>1982</year>
<volume>5</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>264-5</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Curran]]></surname>
<given-names><![CDATA[CF]]></given-names>
</name>
<name>
<surname><![CDATA[Luce]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ocular adverse reactions associated with adriamycin (doxorubicin)]]></article-title>
<source><![CDATA[Am J Ophthalmol]]></source>
<year>1989</year>
<volume>108</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>709-11</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valanis]]></surname>
<given-names><![CDATA[BG]]></given-names>
</name>
<name>
<surname><![CDATA[Vollmer]]></surname>
<given-names><![CDATA[WM]]></given-names>
</name>
<name>
<surname><![CDATA[Labuhn]]></surname>
<given-names><![CDATA[KT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel]]></article-title>
<source><![CDATA[Am J Hosp Pharm]]></source>
<year>1993</year>
<volume>50</volume>
<page-range>455-62</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McDiarmid]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Egan]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute occupational exposure to antineoplastic agents]]></article-title>
<source><![CDATA[J Occup Med]]></source>
<year>1988</year>
<volume>30</volume>
<page-range>984-7</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Puckett]]></surname>
<given-names><![CDATA[WH]]></given-names>
</name>
<name>
<surname><![CDATA[Dana]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Nguyen]]></surname>
<given-names><![CDATA[TV]]></given-names>
</name>
<name>
<surname><![CDATA[Theiss]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Matney]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk of handling injectable antineoplastic agents]]></article-title>
<source><![CDATA[Am J Hosp Pharm]]></source>
<year>1982</year>
<volume>39</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1881-7</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nguyen]]></surname>
<given-names><![CDATA[TV]]></given-names>
</name>
<name>
<surname><![CDATA[Theiss]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Matney]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exposure of pharmacy personnel to mutagenic antineoplastic drugs]]></article-title>
<source><![CDATA[Cancer Res]]></source>
<year>1982</year>
<volume>42</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>4792-6</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Selevan]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
<name>
<surname><![CDATA[Lindbohm]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Hornung]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Hemminki]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A study of occupational exposure to antineoplastic drugs and fetal loss in nurses]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>1985</year>
<volume>313</volume>
<numero>19</numero>
<issue>19</issue>
<page-range>1173-8</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hemminki]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Kyyrönen]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Lindbohm]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on registered information of outcome]]></article-title>
<source><![CDATA[J Epidemiol Community Health]]></source>
<year>1985</year>
<volume>39</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>141-7</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sessink]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kroese]]></surname>
<given-names><![CDATA[ED]]></given-names>
</name>
<name>
<surname><![CDATA[van Kranen]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bos]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer risk assessment for health care workers occupationally exposed to cyclophosphamide]]></article-title>
<source><![CDATA[Int Arch Occup Environ Health]]></source>
<year>1995</year>
<volume>67</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>317-23</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="book">
<collab>Instituto Nacional de Seguridad e Higiene en el Trabajo</collab>
<source><![CDATA[Guía técnica para la evaluación y prevención de los riesgos relacionados con la exposición durante el trabajo a agentes cancerígenos y mutágenos]]></source>
<year>2009</year>
<publisher-loc><![CDATA[Madrid, España ]]></publisher-loc>
<publisher-name><![CDATA[INSHT]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valero García]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[López Bri]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Vila Clérigues]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Poveda Andrés]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicamentos biopeligrosos: nuevos retos, nuevas oportunidades]]></article-title>
<source><![CDATA[Farm Hosp]]></source>
<year>2016</year>
<volume>40</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>124-30</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Erce]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Preventing occupational exposure to cytotoxic and other hazardous drugs. European Policy Recommendations]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Bruselas, Bélgica ]]></publisher-loc>
<publisher-name><![CDATA[Rohde Public Policy]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="book">
<collab>Comisión Europea</collab>
<source><![CDATA[Marco estratégico de la UE en materia de salud y seguridad en el trabajo 2021-2027]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Bruselas, Bélgica ]]></publisher-loc>
<publisher-name><![CDATA[Comisión Europea]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Directiva 2004/37/CE del Parlamento Europeo y del Consejo de 29 de abril de 2004 relativa a la protección de los trabajadores contra los riesgos relacionados con la exposición a agentes carcinógenos o mutágenos durante el trabajo]]></article-title>
<source><![CDATA[Diario Oficial de las Comunidades Europeas]]></source>
<year>2004</year>
<numero>158</numero>
<issue>158</issue>
</nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="book">
<collab>European Commission. Directorate General for Employment, Social Affairs and Inclusion</collab>
<source><![CDATA[Guidance for the safe management of hazardous medicinal products at work]]></source>
<year>2023</year>
<publisher-loc><![CDATA[LU ]]></publisher-loc>
<publisher-name><![CDATA[Publications Office]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Poveda]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Zamudio]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sanz Villorejo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Cobos]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez de Aramayona]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Muedra]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Documento de Consenso de Sociedades Científicas. Seguridad del paciente y del profesional sanitario en la preparación y administración de medicinas peligrosas]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Madrid, España ]]></publisher-loc>
<publisher-name><![CDATA[Sociedades Científicas Españolas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="book">
<collab>The Hazardous Drug Consensus Group</collab>
<source><![CDATA[Consensus Statement on the Handling of Hazardous Drugs: Per USP Chapter]]></source>
<year>2017</year>
<publisher-loc><![CDATA[North Carolina, USA ]]></publisher-loc>
<publisher-name><![CDATA[Hazardous Drug Consensus Statement]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bernabeu-Martínez]]></surname>
<given-names><![CDATA[MÁ]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Tormo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[García-Salom]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sanz-Valero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Wanden-Berghe]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Perception of risk of exposure in the management of hazardous drugs in home hospitalization and hospital units]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Walton]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[PLOS ONE]]></source>
<year>2021</year>
<volume>16</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
